Hosted by Syneos Health · EN-US · 18 episodes
Established thought leaders with verified media credentials.
Commercialization is becoming more tightly connected to decisions across the biopharma journey, from value and access to launch strategy, deployment and patient, provider and advocacy engagement. Conversations on Commercialization is the latest addition to the Syneos Health Podcast family, featuring leaders and experts from across the industry discussing the strategies, challenges and shifts shaping commercial success in today’s market. Each episode explores how companies are approaching the issues that matter most in commercialization and what it takes to compete more effectively in today’s market. Subscribe to The Syneos Health Podcast: Conversations on Commercialization for new episodes. If there’s a topic you’d like us to explore, send us a message at podcasts@syneoshealth.com . For more actionable, future-focused life sciences insights, visit the <a href=
Syneos Health hosts The Syneos Health Podcast: Conversations on Commercialization, a business show with 18 episodes published.
Recorded from the floor of Asembia 2026, this episode explores how biopharma leaders are rethinking reimbursement, patient access and commercial strategy in an increasingly complex market. Host Kim Plesnarski is joined b
Recorded on the ground at the Asembia Summit 2026, this episode of the Syneos Health Podcast explores how stronger collaboration, connected care models and patient-centered listening can improve access, affordability and
In this episode of Conversations on Commercialization, host Michael Sarshad, Managing Director, Consulting at Syneos Health, talks with KAI CEO David Williams and Deanne Melloy, CCO Deployment Solutions at Syneos Health,
In this episode, Tyler Cowan, VP, Commercial speaks with Paul Rittman, President and General Manager of Almirall US, about how payer consolidation and PBM influence are reshaping dermatology commercialization. They discu
What if drug naming could be faster, smarter and more aligned to brand strategy? In this episode, Addison Whitney’s Joe Daley, President, and Bill Purdy, SVP and Managing Director of Global Brand Development & Strategy,
Recorded at Fierce Pharma Week 2025, the conversation continues with part two of our conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard and host Tyler Cowan turn the lens to pa
Recorded at Fierce Pharma Week 2025, here is the first episode in a two-part series with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard joins host Tyler Cowan, VP, Commercial at Syneos Healt
Host Tyler Cowan, VP Commercial at Syneos Health, joins Hruta Shah, Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes race in obesity treatment and the commercial boom around GLP-1 the
In this special episode recorded from the floor at Asembia’s AXS25 Summit, host Michael Sarshad sits down with Tiara Green, President of Accessia Health, to explore the evolving landscape of patient support. They discuss
In this special edition of the Syneos Health Podcast recorded from the floor of Asembia’s AXS25 Summit, host Michael Sarshad speaks with Kim Plesnarski, SVP of Market Access and Patient Support Services at Syneos Health
The biopharma market is booming—but not without turbulence. In this kickoff episode of our special podcast series in collaboration with Asembia, hosts Michael Sarshad, Managing Director, Commercial Advisory, Syneos Healt
In this episode, host Sara Rubin is joined by Cheryl Allen, RPh, founding partner at Curatio Advisors, to explore how manufacturers can evolve their access strategies in response to the growing complexity of specialty-li
In this episode of our Navigating Modern Market Access series, recorded from the floor of Asembia's AXS25 Summit, host Sara Rubin sits down with Rob Truckenmiller, the newly appointed CEO of PharmaCord. Drawing from his
Recorded from the floor of Asembia’s AXS25 Summit, host Michael Sarshad sits down with Kim Plesnarski, SVP of Market Access and Patient Support Services at Syneos Health and Kelly Carter, AVP of Patient Support at Amgen,
Hosted by Drew Beck, Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions, this limited series dives into the breakthrough trends redefining health in 2025 and beyond. From bold moves in R&D and m
2025 Health Trends meets The Syneos Health Podcast for a limited series exploring how Trends come alive in the life sciences industry with host Drew Beck, Head of Strategy, Growth and Innovation for Syneos Health Learnin
Hosted by Drew Beck, Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions, this limited series dives into the breakthrough trends redefining health in 2025 and beyond. From bold moves in R&D and m
Commercialization decisions are shaping success earlier than ever in the product lifecycle, from value and access to launch strategy, deployment and stakeholder engagement. Conversations on Commercialization, a new spino
David Williams
Leiter Programm für internationale Klimagerechtigkeit · North Carolina Central University
1 appearance on this show
Greg Morris
Chief Strategy Officer · New York City Employment and Training Coalition
1 appearance on this show
Kelly Carter
Certified Nutrition Practitioner and Wellness and Mindset Coach · Amgen
1 appearance on this show
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
The Syneos Health Podcast: Conversations on Commercialization has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their business audience.
The Syneos Health Podcast: Conversations on Commercialization is hosted by Syneos Health. The show is categorised under business (marketing) and has published 18 episodes.
The Syneos Health Podcast: Conversations on Commercialization has published 18 episodes.
The Syneos Health Podcast: Conversations on Commercialization regularly covers business, marketing. It sits in the business category, with a marketing focus.
The Syneos Health Podcast: Conversations on Commercialization is accessible for guests with genuine business expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
The Syneos Health Podcast: Conversations on Commercialization hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of The Syneos Health Podcast: Conversations on Commercialization average 18 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates The Syneos Health Podcast: Conversations on Commercialization's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 9 days ago.
